A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis

This study has been completed.

Study NCT00034476 Information provided by Eli Lilly and Company

First Received: April 29, 2002 Last Updated: July 18, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	October 2002
Estimated Primary Completion Date:	No date given